CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

Historical Holders from Q1 2019 to Q3 2025

Symbol: CLOV on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 416,598,522
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 135,304,614
Holdings value: $413,984,387
% of all portfolios: 0.001%
Number of holders: 198
Number of buys: 87
Number of sells: -87
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	7.2%		$83,180,072		29,813,646		BlackRock, Inc.	30 Jun 2025
VANGUARD GROUP INC	5.82%		$67,646,435		24,246,034		The Vanguard Group	30 Jun 2025

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	135,304,614	$413,984,387	-$32,285,796	$10,238,274	$22,404,582	$3.06	198
2025 Q2	146,128,655	$407,670,376	+$107,801,104	$6,139,215	$10,026,258	$2.79	197
2025 Q1	105,851,444	$380,012,727	+$48,891,922	$7,601,107	$10,878,777	$3.59	197
2024 Q4	92,775,680	$292,290,234	+$33,084,501	$7,416,146	$16,773,641	$3.15	173
2024 Q3	82,031,282	$231,318,941	+$27,492,527	$6,511,098	$12,908,268	$2.82	154
2024 Q2	73,223,084	$90,062,636	-$13,953,079	$1,771,077	$2,489,889	$1.23	121
2024 Q1	89,442,327	$71,016,376	-$5,911,907	$1,141,077	$1,375,667	$0.794	132
2023 Q4	96,511,448	$91,887,186	+$2,277,396	$1,091,487	$2,712,041	$0.9521	141
2023 Q3	93,620,098	$101,107,320	-$3,078,475	$1,634,256	$3,376,944	$1.08	138
2023 Q2	96,771,026	$86,789,528	-$22,993,945	$1,135,112	$1,796,645	$0.8971	140
2023 Q1	122,809,816	$103,788,732	-$1,403,557	$1,020,766	$1,796,494	$0.8451	150
2022 Q4	126,098,230	$117,195,358	+$72,200	$1,422,094	$2,506,233	$0.9295	167
2022 Q3	123,383,724	$209,751,673	-$931,167	$3,698,000	$4,346,000	$1.7	150
2022 Q2	122,450,162	$262,010,857	+$44,394,028	$4,585,000	$8,029,000	$2.14	156
2022 Q1	99,563,575	$353,476,882	-$114,782,509	$22,928,000	$20,523,000	$3.55	147
2021 Q4	130,139,458	$484,243,395	+$81,897,100	$21,801,000	$27,000,000	$3.72	144
2021 Q3	105,648,029	$780,734,717	-$325,418,528	$76,593,000	$118,801,000	$7.39	131
2021 Q2	141,911,833	$1,889,729,052	-$201,269,843	$137,070,000	$261,969,000	$13.32	132
2021 Q1	160,035,962	$1,206,298,896	+$1,205,006,987	$31,342,000	$56,134,000	$7.56	118
2020 Q4	74,874	$1,256,000	+$837,000			$16.76	9
2020 Q3	0	$0	-$113,000	$0	$3,000	$3.75	0
2020 Q2					$3,000	$3.75	0
2020 Q1	15,000	$113,000		$106,000	$3,000	$7.53	1
2019 Q4					$3,000	$3.75	0
2019 Q3					$3,000	$3.75	0
2019 Q2					$3,000	$3.75	0
2019 Q1					$3,000	$3.75	0